课题基金 / 基金详情

项目摘要

项目成果

DAVID P RICHMAN的其他基金

相似基金

相关文献

中文摘要
翻译
这个项目的总体目标是分析自身免疫反应 乙酰胆碱受体(ACHR)在重症肌无力(MG)及其 实验模型,实验性自身免疫性重症肌无力(EAMG),和 来操纵自身抗体的表达 该分析将 为开发抗原特异性或独特位提供基础 (Id)-MG(以及其他自身免疫性疾病)的特异性治疗 这将比目前可用的更有效,毒性更小, 治疗 T细胞和B细胞免疫原性的系统研究 EAMG敏感株和耐药株AChR的表位 以确定T细胞库在小鼠免疫应答中的作用。 将进行抗体反应的多样性。 T细胞 来自T细胞克隆的受体(TcR)V区基因片段的使用 针对免疫原性T细胞表位的抗体将在血清学上确定 并对这些细胞克隆的cDNA或基因组DNA进行测序。 后者 研究将确定是否限制TcR基因片段的使用, 在T细胞介导的自身免疫性疾病中观察到,实验性过敏 脑脊髓炎,也发生在抗体介导的,T细胞控制的 EAMG中的自身免疫反应。 此外,阻断EAMG的有效性 将评估针对重要TcR的抗克隆型应答。 此外,还探讨了T细胞在注射EAMG中的保护作用。 将分析先前开发的抗Id单克隆抗体。 这些研究将涉及T细胞的过继转移, 动物到未处理动物的TcR基因片段使用的测定, 保护动物。 拟议的实验将主要利用 pepscanning法检测T细胞和B细胞AChR表位 免疫原性,T细胞克隆和杂交瘤的开发,扩增 cDNA和基因组DNA的聚合酶链反应,并直接测序 以确定TcR基因片段的使用。
英文摘要
The overall goal of this project is to analyze the autoimmune response to the acetylcholine receptor (ACHR) in myasthenia gravis (MG) and its experimental model, experimental autoimmune myasthenia gravis (EAMG), and to manipulate the expression of the autoantibodies. This analysis will provide the groundwork for the development of antigen-specific, or idiotope (Id)-specific, treatments of MG (and other autoimmune diseases as well) that will be more effective and less toxic than presently available therapies. A systematic survey of both the T cell and B cell immunogenic epitopes of the entire AChR in EAMG-susceptible and EAMG-resistant strains of mice in order to determine the role of the T cell repertoire in the diversity of the antibody response will be carried out. The T cell receptor (TcR) V region gene segment usage from T cell clones directed against the immunogenic T cell epitopes will be determined serologically and by sequencing cDNA or genomic DNA from these cell clones. The latter studies will determine whether the restricted TcR gene segment usage observed in the T-cell-mediated autoimmune disease, experimental allergic encephalomyelitis, also occurs in the antibody-mediated, T-cell-controlled autoimmune response in EAMG. Moreover, the effectiveness in blocking EAMG of anti-clonotypic responses against important TcRs will be assessed. Also, the role of T cells in the protection from EAMG induced by injection of, previously developed, anti-Id monoclonal antibodies will be analyzed. These studies will involve adoptive transfer of T cells from protected animals to naive animals and determination of TcR gene segment usage in the protected animals. The proposed experiments will primarily make use of the pepscanning procedure to survey the AChR epitopes for T cell and B cell immunogenicity, development of T cell clones and hybridomas, amplification of cDNA and genomic DNA by polymerase chain reaction, and direct sequencing of amplified products to determine TcR gene segment usage.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Development of Animal Models of Anti-MuSK Myasthenia
Development of Animal Models of Anti-MuSK Myasthenia
IX INTERNATIONAL CONFERENCE ON MYASTHENIA GRAVIS
  • 批准号:
    2038867
  • 项目类别:
  • 资助金额:
    $2.0万
  • 财政年份:
    1997
  • 负责人:
    DAVID P RICHMAN
  • 依托单位:
STRUCTURE/FUNCTION ANALYSIS OF ACCHR EPITOPES
  • 批准号:
    3100129
  • 项目类别:
  • 资助金额:
    $65.68万
  • 财政年份:
    1987
  • 负责人:
    DAVID P RICHMAN
  • 依托单位:
国内基金
海外基金
T-cell Receptor信号通路调控基因的表达机制分子解析
  • 批准号:
    32570839
  • 项目类别:
    面上项目
  • 资助金额:
    50.00万元
  • 批准年份:
    2025
  • 负责人:
    范高峰
  • 依托单位: